Detalhe da pesquisa
1.
Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma.
J Cell Mol Med
; 24(18): 10705-10713, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783366
2.
Recurrent pyogenic cholangitis - an independent poor prognostic indicator for resectable intrahepatic cholangiocarcinoma: A propensity score matched analysis.
HPB (Oxford)
; 20(11): 1067-1072, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30017784
3.
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication.
Gut
; 66(8): 1496-1506, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27974549
4.
Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.
HPB (Oxford)
; 18(1): 72-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26776854